The Indianapolis company raised its expectations for net income for the entire year, and said Thursday it earned $1.3 billion, or $1.18 per share, in the three months that ended Sept. 30.
That’s up from the $941.8 million, or 86 cents per share, in the same period last year, when Lilly recorded nearly $550 million in one-time charges tied to litigation and the sale of a manufacturing site.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
